MoonLake Immunotherapeutics MLTX Other Receivables
Other Receivables at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's other receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's other receivables?
- MoonLake Immunotherapeutics (MLTX) reported other receivables of $5.76M in Q1 2026.
- How has MoonLake Immunotherapeutics's other receivables changed year-over-year?
- MoonLake Immunotherapeutics's other receivables increased by 92.9% year-over-year, from $2.99M to $5.76M.
- What is the long-term trend for MoonLake Immunotherapeutics's other receivables?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's other receivables has grown at a 139.2% compound annual growth rate (CAGR), from $148.77K to $4.87M.
- What does other receivables mean?
- This represents miscellaneous claims for cash or other assets not classified under standard trade accounts receivable. It often includes tax refunds, interest receivables, or non-core operational claims. Monitoring this helps identify potential hidden liquidity issues or delays in cash conversion.